Gold Coast Research LLC Report issue

For profit Phase 3
Founded: Weston FL United States (1988)
Status: No NME R&D (1988)

Organization Overview

First Clinical Trial
2004
NCT00313014
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2004

Timeline

NOW
  • Now

Alternative names

Gold Coast Research LLC, Weston, FL, USA

Active Ingredients

Drugs in Phase 3 Trials (2)

buprenorphine (1 trial)

oxycodone (oxycontin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Back Pain (Phase 3)

Low Back Pain (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 2